Mckesson (MCK) Cash from Investing Activities (2009 - 2026)
Mckesson's (MCK) quarterly Cash from Investing Activities came in at $425.0 million in Q1 2026, up 289.73% year-on-year from $109.0 million in Q1 2025, and up 257.99% on a QoQ basis from -$269.0 million in Q4 2025.
Mckesson (MCK) Cash from Investing Activities (2009 - 2026) Analysis & Trends
Mckesson (MCK) has 18 years of Cash from Investing Activities data on file, last reported at $425.0 million in Q1 2026.
- On a quarterly basis, Cash from Investing Activities rose 289.73% year-over-year to $425.0 million in Q1 2026; TTM through Mar 2026 was -$3.4 billion, a 368.21% decrease from a year earlier, with the FY2026 full-year figure at -$3.4 billion, down 368.21% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at $425.0 million, up from -$269.0 million in the prior quarter.
- Over the last five years, Cash from Investing Activities for MCK reached as high as $425.0 million in Q1 2026 and fell as low as -$3.6 billion in Q2 2025.
- Historically, Cash from Investing Activities has averaged -$329.2 million across 5 years, with a median of -$166.0 million in 2023.
- Across the five-year window, Cash from Investing Activities tumbled 3996.55% in 2025 and surged 289.73% in 2026, its largest moves.
- Year by year, Cash from Investing Activities stood at -$414.0 million in 2022, then jumped by 56.52% to -$180.0 million in 2023, then rose by 24.44% to -$136.0 million in 2024, then plunged by 97.79% to -$269.0 million in 2025, then soared by 257.99% to $425.0 million in 2026.
- Per Business Quant data, the three most recent Cash from Investing Activities figures were $425.0 million in Q1 2026, -$269.0 million in Q4 2025, and -$24.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 105.15 Bn | 101.18 Bn | 4.04 Bn | 425.00 Mn |
| 2 | Cencora | 60.58 Bn | 58.40 Bn | 3.59 Bn | -4.87 Bn |
| 3 | Cardinal Health | 53.81 Bn | 49.87 Bn | 2.50 Bn | -181.00 Mn |
| 4 | Henry Schein | 9.71 Bn | 9.57 Bn | 1.07 Bn | -63.00 Mn |
| 5 | Akso Health | 3.28 Bn | 3.28 Bn | - | - |
| 6 | 111 | 651.73 Mn | 572.63 Mn | 23.58 Mn | -3.21 Mn |
| 7 | Accendra Health | 248.02 Mn | -88.86 Mn | 278.03 Mn | 53.93 Mn |
| 8 | Edap Tms | 230.14 Mn | 215.14 Mn | 8.15 Mn | -754,000.00 |
| 9 | VitaNova Life Sciences | 11.51 Mn | 11.01 Mn | 316,343.00 | - |
| 10 | Cosmos Health | 9.57 Mn | 7.41 Mn | 1.38 Mn | -708,963.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 425.00 Mn |
| Mar 31, 2026 | 425.00 Mn |
| Dec 31, 2025 | -269.00 Mn |
| Dec 31, 2025 | -269.00 Mn |
| Sep 30, 2025 | -24.00 Mn |
| Sep 30, 2025 | -24.00 Mn |
| Jun 30, 2025 | -3.56 Bn |
| Jun 30, 2025 | -3.56 Bn |
| Mar 31, 2025 | -224.00 Mn |
| Mar 31, 2025 | -224.00 Mn |
| Dec 31, 2024 | -136.00 Mn |
| Dec 31, 2024 | -136.00 Mn |
| Sep 30, 2024 | -286.00 Mn |
| Sep 30, 2024 | -286.00 Mn |
| Jun 30, 2024 | -87.00 Mn |
| Jun 30, 2024 | -87.00 Mn |
| Mar 31, 2024 | -577.00 Mn |
| Mar 31, 2024 | -577.00 Mn |
| Dec 31, 2023 | -180.00 Mn |
| Dec 31, 2023 | -180.00 Mn |